Search

everythinglearnresearchcommunity

for

Search:↓

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

The treatment was not recommended due to limited effectiveness and significant side effects.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

The combination therapy was effective and well-tolerated, especially in young patients.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Tofacitinib might be used to treat hair loss.

Pulsed electric field treatment may help shrink untreated liver tumors.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.